FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1871-1879 June 30, 1994 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Systemic Lupus Erythematosus (SLE) is defined by its clinical features and by the almost invariable presence in the blood of antibodies directed against one or more components of cell nuclei. Certain manifestations seem to be associated with the presence of different antinuclear antibodies and genetic markers, which suggests that SLE may be a family of diseases. However, clinical presentations frequently overlap, and there is currently no conclusive evidence that SLE is more than a single disorder with a broad range of manifestations, the expression of which may be influenced by the patient's genetic background. Occasionally patients have features of both . . . [Full Text of this Article]

Diagnosis

Drug-Induced Lupus Erythematosus

Clinical Course

Pathogenesis

Clinical Characteristics

Treatment

Conclusions

Source Information

From Harvard Medical School and Massachusetts General Hospital, Boston.

Address reprint requests to Dr. Mills at Massachusetts General Hospital, Ambulatory Care Center, Boston, MA 02114.

References

Related Letters:

Diuretic Therapy and the Risk of Cardiac Arrest
Moser M., Gifford R., Siscovick D. S., Koepsell T. D., Raghunathan T.E.
Extract | Full Text  
N Engl J Med 1994; 331:1235-1236, Nov 3, 1994. Correspondence

This article has been cited by other articles:

• Ogawa, A., Firth, A. L., Yao, W., Rubin, L. J., Yuan, J. X.-J. (2008). Prednisolone inhibits PDGF-induced nuclear translocation of NF-{kappa}B in human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L648-L657 [Abstract] [Full Text]  
• Avery, D. T., Bryant, V. L., Ma, C. S., de Waal Malefyt, R., Tangye, S. G. (2008). IL-21-Induced Isotype Switching to IgG and IgA by Human Naive B Cells Is Differentially Regulated by IL-4. J. Immunol. 181: 1767-1779 [Abstract] [Full Text]  
• Negron, A., Molina, M., Mayor, A., Rodriguez, V., Vila, L. (2008). Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico. Lupus 17: 348-354 [Abstract]  
• Nazarinia, M., Ghaffarpasand, F, Shamsdin, A, Karimi, A., Abbasi, N, Amiri, A (2008). Systemic lupus erythematosus in the Fars Province of Iran. Lupus 17: 221-227 [Abstract]  
• Beier, F., Balabanov, S., Amberger, C.C., Hartmann, U., Manger, K., Dietz, K., Kotter, I., Brummendorf, T.H. (2007). Telomere length analysis in monocytes and lymphocytes from patients with systemic lupus erythematosus using multi-color flow-FISH. Lupus 16: 955-962 [Abstract]  
• Groom, J. R., Fletcher, C. A., Walters, S. N., Grey, S. T., Watt, S. V., Sweet, M. J., Smyth, M. J., Mackay, C. R., Mackay, F. (2007). BAFF and MyD88 signals promote a lupuslike disease independent of T cells. JEM 204: 1959-1971 [Abstract] [Full Text]  
• Valencia, X., Yarboro, C., Illei, G., Lipsky, P. E. (2007). Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus. J. Immunol. 178: 2579-2588 [Abstract] [Full Text]  
• Vila, L M, Molina, M J, Mayor, A M, Peredo, R A, Santaella, M L, Vila, S (2006). Clinical and prognostic value of autoantibodies in Puerto Ricans with systemic lupus erythematosus. Lupus 15: 892-898 [Abstract]  
• Hung, J., Wood, C. A., Woronik, V., Vieira, J. M. Jr, Barros, R. T. (2006). Protein-losing gastroenteropathy in a patient with systemic lupus erythematosus and antiphospholipid antibody syndrome simulating nephrotic syndrome. Nephrol Dial Transplant 21: 2027-2028 [Full Text]  
• Burt, R. K., Traynor, A., Statkute, L., Barr, W. G., Rosa, R., Schroeder, J., Verda, L., Krosnjar, N., Quigley, K., Yaung, K., Villa, BS, M., Takahashi, M., Jovanovic, B., Oyama, Y. (2006). Nonmyeloablative Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus. JAMA 295: 527-535 [Abstract] [Full Text]  
• Baranda, L., de la Fuente, H., Layseca-Espinosa, E., Portales-Perez, D., Nino-Moreno, P., Valencia-Pacheco, G., Abud-Mendoza, C., Alcocer-Varela, J., Gonzalez-Amaro, R. (2005). IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus. Rheumatology (Oxford) 44: 1507-1513 [Abstract] [Full Text]  
• Wong, C. K., Lit, L. C. W., Tam, L. S., Li, E. K., Lam, C. W. K. (2005). Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford) 44: 989-994 [Abstract] [Full Text]  
• Wong, C. K., Lit, L. C. W., Tam, L. S., Li, E. K., Lam, C. W. K. (2005). Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford) 44: 602-606 [Abstract] [Full Text]  
• Zhang, X. K., Gallant, S., Molano, I., Moussa, O. M., Ruiz, P., Spyropoulos, D. D., Watson, D. K., Gilkeson, G. (2004). Decreased Expression of the Ets Family Transcription Factor Fli-1 Markedly Prolongs Survival and Significantly Reduces Renal Disease in MRL/lpr Mice. J. Immunol. 173: 6481-6489 [Abstract] [Full Text]  
• Tomita, M., Dragoman, M., Worcester, H., Conran, P., Santoro, T. J. (2004). Proinflammatory Cytokine Genes Are Constitutively Overexpressed in the Heart in Experimental Systemic Lupus Erythematosus: A Brief Communication. Exp. Biol. Med. 229: 971-976 [Abstract] [Full Text]  
• Vila, L. M., Alarcon, G. S., McGwin, G. Jr, Friedman, A. W., Baethge, B. A., Bastian, H. M., Fessler, B. J., Reveille, J. D. (2004). Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Rheumatology (Oxford) 43: 358-363 [Abstract] [Full Text]  
• Peterson, P L, Howe, F A, Clark, C A, Axford, J S (2003). Quantitative magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus. Lupus 12: 897-902 [Abstract]  
• Weide, R, Heymanns, J, Pandorf, A, Koppler, H (2003). Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy. Lupus 12: 779-782 [Abstract]  
• Iwai, H., Abe, M., Hirose, S., Tsushima, F., Tezuka, K., Akiba, H., Yagita, H., Okumura, K., Kohsaka, H., Miyasaka, N., Azuma, M. (2003). Involvement of Inducible Costimulator-B7 Homologous Protein Costimulatory Pathway in Murine Lupus Nephritis. J. Immunol. 171: 2848-2854 [Abstract] [Full Text]  
• Duncan, H. V., Achara, G. (2003). A Rare Initial Manifestation of Systemic Lupus Erythematosus--Acute Pancreatitis: Case Report and Review of the Literature. J Am Board Fam Med 16: 334-338 [Abstract] [Full Text]  
• O'Sullivan, B. P., Erickson, L. A., Niles, J. L. (2002). Case 30-2002 - An Eight-Year-Old Girl with Fever, Hemoptysis, and Pulmonary Consolidations. NEJM 347: 1009-1017 [Full Text]  
• Obermoser, G, Bellmann, R, Pfausler, B, Schmutzhard, E, Sepp, N (2002). Aseptic meningo-encephalitis related to dexibuprofen use in a patient with systemic lupus erythematosus: a case report with MR findings. Lupus 11: 451-453 [Abstract]  
• Himeji, D., Horiuchi, T., Tsukamoto, H., Hayashi, K., Watanabe, T., Harada, M. (2002). Characterization of caspase-8L: a novel isoform of caspase-8 that behaves as an inhibitor of the caspase cascade. Blood 99: 4070-4078 [Abstract] [Full Text]  
• Higuchi, T., Aiba, Y., Nomura, T., Matsuda, J., Mochida, K., Suzuki, M., Kikutani, H., Honjo, T., Nishioka, K., Tsubata, T. (2002). Cutting Edge: Ectopic Expression of CD40 Ligand on B Cells Induces Lupus-Like Autoimmune Disease. J. Immunol. 168: 9-12 [Abstract] [Full Text]  
• Blanco, P., Palucka, A. K., Gill, M., Pascual, V., Banchereau, J. (2001). Induction of Dendritic Cell Differentiation by IFN-alpha in Systemic Lupus Erythematosus. Science 294: 1540-1543 [Abstract] [Full Text]  
• Helfgott, S. M., Kratz, A. (2001). Case 19-2001- A 50-Year-Old Man with Fever and Joint Pain. NEJM 344: 1929-1935 [Full Text]  
• Schmidt, J., Gold, R., Schonrock, L., Zettl, U. K., Hartung, H.-P., Toyka, K. V. (2000). T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy. Brain 123: 1431-1441 [Abstract] [Full Text]  
• Guccione, J. L. (1999). Palmar Ulceration. Arch Dermatol 135: 845-850 [Full Text]  
• Vila, L M, Mayor, A M, Valentin, A H, Garcia-Soberal, M, Vila, S (1999). Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus. Lupus 8: 279-286 [Abstract]  
• Gansauge, S, Breitbart, A, Rinaldi, N, Schwarz-Eywill, M (1997). Methotrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease). Ann Rheum Dis 56: 382-385 [Abstract] [Full Text]  
• Punnonen, J., Cocks, B. G., Carballido, J. M., Bennett, B., Peterson, D., Aversa, G., Vries, J. E. d. (1997). Soluble and Membrane-bound Forms of Signaling Lymphocytic Activation Molecule (SLAM) Induce Proliferation and Ig Synthesis by Activated Human B Lymphocytes. JEM 185: 993-1004 [Abstract] [Full Text]  
• Shoenfeld, Y., Krause, I., Blank, M. (1997). New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation. Ann Rheum Dis 56: 5-11 [Abstract] [Full Text]  
• Sels, F., Dequeker, J., Verwilghen, J., Mbuyi-Muamba, J-M. (1996). SLE and osteoporosis: dependence and/or independence on glucocorticoids. Lupus 5: 89-92  
• Hohler, T., Meyer zum Buschenfelde, K.-H., Deapen, D., Mills, J. A. (1994). Systemic Lupus Erythematosus. NEJM 331: 1235-1235 [Full Text]